CME Group, the world’s leading and most diverse derivatives marketplace, today announced that it has named Alexander (Sasha) Rozenberg as managing director, Over-the-Counter Risk for CME Clearing. Rozenberg, 39, will be responsible for advancing the company’s over-the-counter (OTC) risk management policies and practices. He will be based in New York and will report to Tim Doar, Managing Director, Risk Management.
Rozenberg joins CME Group from SuperDerivatives, a derivatives solution provider, where he served as Product Manager, Credit Derivatives and Acting Head of Quantitative Analytics, and led the development of the company’s credit derivatives pricing and analytics platform. He has significant experience working for the financial engineering arms of three major OTC dealers – Goldman Sachs, JPMorganChase and Morgan Stanley. He earned a bachelor’s degree in physics from the Moscow Institute of Physics and Technology and a PhD in theoretical physics from New York University.
CME Group offers CME ClearPort®, a set of flexible clearing services open to OTC market participants to substantially mitigate counterparty risk and provide neutral settlement prices across asset classes. As of August 2010, CME ClearPort clears more than 460,000 contracts daily, brings together more than 10,000 registered global users and features more than 700 listed contracts available for clearing. Please visit http://www.cmegroup.com/clearport/ for more information.
